bpc-157 fda warning october 2025 On August 15 2025, the U.S. Food & Drug Administration (FDA) issued a Letter to Platinum Biologics LLC for marketing umbilical‑cord‑derived products including exosome products (“NanoEx” & “Nano Xsomes”) without approval People are turning themselves into

We never test our own products the testing lab is a separate entity with no financial relationship to Pepta Labs

After consideration of public comments, for CY 2026, we are finalizing our proposal not to nominate ( CPT codes 96920, 92921, and 96922 as potentially misvalued

The panel selected to review the evidence in July is made up of members who have ties to the peptide industry, including some who work for companies that offer injectable peptides

Conditions such as inflammatory bowel disease (IBD), leaky gut syndrome, celiac disease recovery, autoimmune diseases, and mast cell activation syndrome (MCAS) can be incredibly challenging to manage

Vitamin B increases nutrient absorption and maximizes their bioavailability for the whole body's benefit